The DOI matches its Crossref record.
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Abstract
We propose a model of drug pharmacodynamic response that when integrated with a pharmacokinetic model allows characterization of the temporal aspects of pharmacodynamics as well as the time‐independent sensitivity component. The total model can accommodate extremes of effect. It allows fitting of simultaneous plasma concentration (Cp) and effect data from the initial distribution phase of drug administration, or from any non‐equilibrium phase. The model postulates a hypothetical effect compartment, the dynamics of which are adjusted to reflect the temporal dynamics of drug effect. The effect compartment is modeled as an additional compartment linked to the plasma compartment by a first‐order process, but whose exponential does not enter into the pharmacokinetic solution for the mass of drug in the body. The hypothetical amount of drug in the effect compartment is then related to the observed effect by the Hill equation, a nonlinear sigmoid form. Nonlinear least‐squares data fitting is used for parameter estimation. The model is demonstrated on two different sets of Cp and effect data for the drug d‐tubocurarine (dTC). In 7 normal subjects, the (mean ± SD) rate constant for equilibration of dTC effect (paralysis) and Cp is 0.13 ± 0.04 min−1 and the (mean ± SD) steady‐state Cp required to produce 50% paralysis is 0.37 ± 0.05 µg/ml.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Holford, N. H. G., & Sheiner, L. B. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106060-00002 · Cited by 1,143
Self-citationThe Influence of Age on Propofol Pharmacodynamics
Schnider, T. W., Minto, C. F., Shafer, S. L., Gambus, P. L., Andresen, C., Goodale, D. B., & Youngs, E. J. (1999) · Anesthesiology · doi:10.1097/00000542-199906000-00003 · Cited by 1,064
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Comparison of four basic models of indirect pharmacodynamic responses
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061691 · Cited by 821
Kinetics of pharmacologic response
Holford, N. H. G., & Sheiner, L. B. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90051-1 · Cited by 501
Self-citationLALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
Measured Context-sensitive Half-times of Remifentanil and Alfentanil
Kapila, A., Glass, P. S. A., Jacobs, J. R., Muir, K. T., Hermann, D. J., Shiraishi, M., Howell, S., & Smith, R. L. (1995) · Anesthesiology · doi:10.1097/00000542-199511000-00009 · Cited by 393
Evaluation of Combination Chemotherapy
Zhao, L., Wientjes, M. G., & Au, J. L.-S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1087 · Cited by 379
Sex Differences in Morphine Analgesia: An Experimental Study in Healthy Volunteers
Sarton, E., Olofsen, E., Romberg, R., den Hartigh, J., Kest, B., Nieuwenhuijs, D., Burm, A., Teppema, L., & Dahan, A. (2000) · Anesthesiology · doi:10.1097/00000542-200011000-00018 · Cited by 360
Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives
Derendorf, H., & Meibohm, B. (1999) · Pharmaceutical Research · doi:10.1023/a:1011907920641 · Cited by 352
Diversity of Mechanism-Based Pharmacodynamic Models
Mager, D. E., Wyska, E., & Jusko, W. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.510 · Cited by 345
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Data‐derived safety factors for the evaluation of food additives and environmental contaminants
Renwick, A. G. (1993) · Food Additives and Contaminants · doi:10.1080/02652039309374152 · Cited by 321
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
Population Pharmacokinetics/Dynamics*
Sheiner, L. B., & Ludden, T. M. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001153 · Cited by 316
Self-citationLong‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Vauquelin, G., & Charlton, S. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00936.x · Cited by 298
Vuyk, J., Mertens, M. J., Olofsen, E., Burm, A. G. L., & Bovill, J. G. (1997) · Anesthesiology · doi:10.1097/00000542-199712000-00033 · Cited by 285
Upton, R., & Mould, D. (2014) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.71 · Cited by 265
Human Variability and Noncancer Risk Assessment— An Analysis of the Default Uncertainty Factor
Renwick, A. G., & Lazarus, N. R. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1195 · Cited by 261
Danhof, M., de Jongh, J., De Lange, E. C. M., Della Pasqua, O., Ploeger, B. A., & Voskuyl, R. A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105154 · Cited by 258
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle, M. E., & Egan, J. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.7 · Cited by 256
Nielsen, E. I., Cars, O., & Friberg, L. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-11 · Cited by 254
Shafer, S. L., & Gregg, K. M. (1992) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01070999 · Cited by 252
Population pharmacokinetics of metformin in late pregnancy
Charles, B., Norris, R., Xiao, X., & Hague, W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000184161.52573.0e · Cited by 212
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0513-9 · Cited by 133
Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects.
Shi, J., Benowitz, N. L., Denaro, C. P., & Sheiner, L. B. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.3 · Cited by 99
Self-citationCaffeine accelerates absorption and enhances the analgesic effect of acetaminophen
Renner, B., Clarke, G., Grattan, T., Beisel, A., Mueller, C., Werner, U., Kobal, G., & Brune, K. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299762 · Cited by 94
Parameter Identifiability of Fundamental Pharmacodynamic Models
Janzén, D. L. I., Bergenholm, L., Jirstrand, M., Parkinson, J., Yates, J., Evans, N. D., & Chappell, M. J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00590 · Cited by 44
Helmlinger, G., Al-Huniti, N., Aksenov, S., Peskov, K., Hallow, K. M., Chu, L., Boulton, D., Eriksson, U., Hamrén, B., Lambert, C., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.028 · Cited by 33
Self-citationWong, H., Bohnert, T., Damian-Iordache, V., Gibson, C., Hsu, C.-P., Krishnatry, A. S., Liederer, B. M., Lin, J., Lu, Q., Mettetal, J. T., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.015 · Cited by 27
Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [11C]DASB PK-PD Study
Kim, E., Howes, O. D., Kim, B.-H., Chon, M.-W., Seo, S., Turkheimer, F. E., Lee, J. S., Lee, Y.-S., & Kwon, J. S. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0444-x · Cited by 15
Metadata
- Authors
- Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1979-03
- Volume
- 25
- Issue
- 3
- Pages
- 358-371
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2324227497
- Cited by
- 1,134
- References
- 0
- FWCI
- 23.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.